Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Genetics
Genetic profiling has advanced our knowledge of non-small cell lung cancer
July 30th, 2004
Genetic profiling has advanced our knowledge of non-small cell lung cancer. According to a study from Scotland, "non-small cell lung cancer (NSCLC) is the most common cause of premature death from malignant disease in western countries. A better understanding of the molecular mechanisms underlying NSCLC etiology, pathogenesis, and therapeutics will lead to improved clinical outcomes. Recent technological advances in gene expression profiling (in particular, with cDNA and oligonucleotide microarrays) allow the simultaneous analysis of the expression of thousands of genes." "In this review, the technology of global gene expression profiling is...
Source: Genomics & Genetics Weekly (2004-07-30)
|
